Two new subtypes of MASH revealed with different risks and outcomes

Fatty Liver News

Two new subtypes of MASH revealed with different risks and outcomes
LiverLiver DiseaseCancer
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 43 sec. here
  • 18 min. at publisher
  • 📊 Quality Score:
  • News: 76%
  • Publisher: 71%

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), impacts roughly 30% of the global adult population.

INSERM Dec 9 2024 Metabolic dysfunction-associated steatotic liver disease , formerly referred to as nonalcoholic fatty liver disease , impacts roughly 30% of the global adult population. The disease spans from benign fat accumulation in the liver to its more severe form, metabolic dysfunction-associated steatohepatitis . MASH represents a dangerous progression, with the potential to cause cirrhosis, liver cancer , type 2 diabetes , and cardiovascular disease .

Two subtypes of MASH, two distinct risk profiles The study identified and validated two distinct types of MASH based on histology and liver imaging, using data from European cohorts and the UK Biobank: "This research marks a turning point," says Prof. François Pattou. "We now have a clear path to develop subtype-specific treatments that can improve patient outcomes."

The science behind the subtypes The study utilized data from the French ABOS cohort of 1,389 individuals with obesity and validated its findings across three European MASLD cohorts , comprising 1,099 participants, as well as imaging data from over 6,000 UK Biobank participants. By integrating clinical traits with liver transcriptomics and plasma metabolomics, researchers uncovered distinct biological pathways driving each subtype.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Liver Liver Disease Cancer Cardiometabolic Cardiovascular Disease Cirrhosis Diabetes Diagnostic Hospital Imaging Liver Cancer Medicine Research Steatosis Type 2 Diabetes UK Biobank

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AI algorithm accurately detects early-stage metabolic-associated steatotic liver diseaseAI algorithm accurately detects early-stage metabolic-associated steatotic liver diseaseLiver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect early-stage metabolic-associated steatotic liver disease (MASLD) by using electronic health records.
Read more »

Time-restricted eating shows promising weight and metabolic benefits, study revealsTime-restricted eating shows promising weight and metabolic benefits, study revealsA comprehensive meta-analysis of RCTs suggests meal timing strategies, such as time-restricted eating, offer moderate weight loss benefits and improved metabolic outcomes. However, evidence quality is limited, necessitating further research.
Read more »

Ultra-processed foods drive obesity and metabolic risksUltra-processed foods drive obesity and metabolic risksItalian researchers reveal a strong link between ultra-processed foods and obesity, highlighting increased cardiometabolic risks in adults with higher UPF consumption. The findings call for urgent dietary changes to combat obesity and promote healthier lifestyles.
Read more »

Immune cells play a key role in movement control and metabolic balanceImmune cells play a key role in movement control and metabolic balanceImmune cells have a surprising and critical role in controlling movement and bridging neural activity with metabolic demands, concludes a groundbreaking study published in Nature by researchers at the University of Copenhagen and Imperial College London.
Read more »

Understanding the pathophysiological relationship between OSA and metabolic syndromeUnderstanding the pathophysiological relationship between OSA and metabolic syndromeCardiovascular diseases remain a leading cause of mortality globally, particularly among individuals with both obstructive sleep apnea (OSA) and metabolic syndrome (MetS).
Read more »

Metabolic Health Is The Next Big Wellness Trend – Here’s 5 Ways To Improve YoursMetabolic Health Is The Next Big Wellness Trend – Here’s 5 Ways To Improve YoursDr Casey Means, a Stanford-trained doctor, shares why metabolic dysfunction is behind a rise in most of the diseases we're seeing in the modern world. Here's how to look after your metabolic health in five simple ways.
Read more »



Render Time: 2025-02-12 00:16:27